Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Valeo Pharma Inc T.VPH

Alternate Symbol(s):  VPHIF | T.VPH.DB

Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler,... see more

Bullboard (TSX:VPH)

View:
Post by joeboo3100on Jan 06, 2022 1:00pm

Debt Free

New to this company, is VPH dept free?
Post by Royal10on Jan 05, 2022 10:17am

VPH: VALEO PHARMA offers COVID-19 product for immune support

Please read this very important news that should be very beneficial for VPH shareholders. The new product: HESPERCO • Clinical study yields encouraging results that hesperidin may help reduce ...more  
Comment by Royal10on Dec 15, 2021 10:38am

RE:Valeo obtains public reimbursement in Quebec and Nova Scotia

Another good news! Next quarter results should convince investors that VHP is deeply undervalued!
Post by Royal10on Dec 10, 2021 10:32am

NFG: $25-million financing closed.

VALEO PHARMA, a  strong growth and succesful pharmaceutical company based in Montreal (selling prescriptions across Canada), has closed a big financing of convertible debentures of $25-million ...more  
Post by CanadianJrson Dec 08, 2021 10:03am

Financials

Does anyone have any idea as to when they are releasing year end financials this month? Can we expect them end of next week or before Christmas holidays? Anything shortly after the close of the Bought ...more  
Comment by Marketwatchmanon Nov 24, 2021 11:22am

RE:VPH

Pershing securities only sells VPH in small batches, it never buys its shares ???
Comment by CanadianJrson Nov 24, 2021 8:19am

RE:$10M Bought Deal Private Placement of Convertible Debentures

Only good news out of that is the TSX up listing being mentioned. Other than that this just costed the company $4.8 million or more in interest over the next 4 years and about 10% dilution if they ...more  
Post by Marketwatchmanon Nov 12, 2021 11:08am

VPH

Pershing definitely does not want to see valeo increase in value
Comment by kooter33on Nov 08, 2021 2:10pm

RE:Loading up

Yes, VPH is a great company with great potential, but next year IMO. This year there are no eyes on it and as you alluded to it is a good time to accumulate if you can wait at least 6 months. GL.
Post by CanadianJrson Nov 04, 2021 12:22pm

Loading up

I do love this time of the year. Everyone is selling and taking their loses for tax time and I save all year to start dollar cost averaging into golden goose companies like this. Don't forget they ...more  
Comment by CanadianJrson Oct 28, 2021 12:02pm

RE:90's

It's just algorithms and lack of liquidity right now plus we are on a garbage exchange. Once they uplist to the TSX and hit EBITIDA positive we'll never see below $1 again.
Comment by Marketwatchmanon Oct 27, 2021 10:37am

RE:90's

Valeo has no more news, so the price of its shares is no longer moving.
Post by JACKTHEBEAR2on Oct 25, 2021 10:45am

90's

Why is holding in the 90's so hard.
Comment by kooter33on Oct 14, 2021 5:55pm

RE:Future thoughts

5 year plan?  4 year plan 2025,,,,, 118M shares O/S FD, Revenues by 2024 projected to be $ 160M based on current product portfolio.  Generally you can expect between 6X to 9X sales ( from IR ...more  
Post by Betteryear2on Oct 13, 2021 8:09pm

Obtains Listings for Redesca in 700 Hospitals

2 Group Purchasing Organizations (GPO) listing agreements cover, Redesca™ and Redesca HP™, as well as 3 other Valeo hospital products The 2 multi-year product listings commenced on October 1, ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities